Transendothelial movement of liposomes in vitro mediated by cancer cells, neutrophils or histamine

Journal of Liposome Research

Volumn 14, Issue 1-2, 2004, Pages 1-25

  Antohe, Felicia ^a   Lin, Lei ^b   Kao, Grace Y ^d   Poznansky, Mark J ^c   Allen, Theresa M ^b  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d Applied Logic Associates Inc   (United States)

Author keywords

Cancer cells; Endothelial cell monolayer; Histamine; Liposome; Neutrophils

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; IMMUNOGLOBULIN G; LIPOSOME;

ARTICLE; CANCER CELL; CELL DISRUPTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

EID: 4744349325     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-120039660     Document Type: Article

References (70)

1. Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS, Cullis PR, Bally MB. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 1989; 49:5922-5930.
2. Bally MB, Nayer R, Masin D, Hope MJ, Cullis PR, Mayer LD. Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta 1990; 1023:133-139.
3. Litzinger DC, Huang L. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes. Biochim Biophys Acta 1992; 1104:179-187.
4. Klibanov AL, Maruyama K, Beckerleg AM, Torchlin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1991; 1062:142-148.
5. Liu D, Huang L. pH-Sensitive, plasma-stable liposomes with relatively prolonged residence in circulation. Biochim Biophys Acta 1990; 1022:348-354.
6. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholtz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994; 54:987-992.
7. Allen TM, Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 1987; 223:42-46.
8. Gabizon A, Papahadjopoulous D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 1988; 85:6949-6953.
9. Allen TM. Stealth liposomes: avoiding reticuloendothelial uptake. In: Lopez-Berestein G, Fidler I, eds. Liposomes in the Therapy of Infectious Diseases and Cancer. Vol. 89. New York: Alan R. Liss, Inc., 1989:405-415. New Series.
10. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990; 268:235-237.
11. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990; 1029:91-97.
12. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066:29-36.
13. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991; 1062:77-82.
14. Allen TM, Hansen C. Pharmacokinetics of Stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1991; 1068:133-141.
15. Allen TM, Mehra T, Hansen C, Chin Y-C. Stealth liposomes: an improved sustained release system for 1-β-D-arabinofuranosylcytosine. Cancer Res 1992; 52:2431-2439.
16. Ahmad I, Allen TM. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Cancer Res 1992; 52:4817-4820.
17. Ahmad I, Longenecker M, Samuel J, Allen TM. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 1993; 53:1484-1488.
18. Huang SK, Mayhew E, Gilani S, Lasic DD, Martin FJ, Papahadjopoulos D. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 1992; 52:6774-6781.
19. Gabizon AA. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated on long-circulating liposomes. Cancer Res 1992; 52:891-896.
20. Bakker-Woudenberg IAJM, Lokerse AF, ten Kate MT, Storm G. Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. Biochim Biophys Acta 1992; 1138:318-326.
21. Woodle MC, Storm G, Newman MS, Jekot JJ, Collins LR, Martin FJ, Szoka FC. Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. Pharm Res 1992; 9:260-265.
22. Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res 2002; 4:95-99.
23. Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res 1990; 50:6371-6378.
24. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee K-D, Woodle MC, Lasic DD, Redemann C, Martin FJ. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 1991; 88:11460-11464.
25. Huang SK, Lee K-D, Hong K, Friend DS, Papahadjopoulos D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 1992; 52:5135-5143.
26. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-593.
27. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118.
28. Bartsch M, Weeke-Klimp AH, Meijer DK, Scherphof GL, Kamps JA. Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells. Pharm Res 2002; 19:670-680.
29. Litzinger DC, Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim Biophys Acta 1992; 1113:201-216.
30. Antohe F, Poznansky MJ. The endothelial monolayer: barrier to enzyme and drug delivery in pharmaceutical enzymes. In: Lauwers A, Scharpé S, eds. Pharmaceutical Enzymes. New York: Marcel Dekker, Inc., 1997:21-31.
31. Simionescu M, Gafencu A, Antohe F. Trancytosis of plasma macromolecules in endothelial cells - a cell biological survey. In: Johnson JE Jr, ed. Microscopy Research and Technique, Vol. 57. New York: Wiley-Liss, Inc., 2002:269-288.
32. Shepard JM, Goderie SK, Brzyski N, Del Vecchio PJ, Malik AB, Kimelberg HK. Effects of alterations in endothelial cell volume on transendothelial albumin permeability. J Cell Physiol 1987; 133:389-394.
33. Pappenheimer JR. Passage of molecules through capillary walls. Physiol Rev 1953; 33:387-423.
34. Albelda SM, Sampson PM, Haselton FR, McNiff JM, Mueller SM, Williams SK, Fishman AP, Levine EM. Permeability characteristics of cultures endothelial cell monolayers. J Appl Physiol 1988; 64:308-322.
35. Vasile E, Antohe F, Simionescu M, Simionescu N. Transport pathways of beta-VLDL by aortic endothelium of normal and hypercholesterolemic rabbits. Atherosclerosis 1989; 75:195-210.
36. Poznansky MJ, Juliano RL. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev 1984; 36:277-336.
37. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 1985; 227:1583-1586.
38. Simionescu M. Receptor-mediated transcytosis of plasma molecules by vascular endothelium. In: Simionescu N, Simionescu M, eds. Endothelial Cell Biology in Health and Disease. New York: Plenum Press, 1988:69-104.
39. Changxin L, Stifani S, Schneider WJ, Poznansky MJ. Low density lipoprotein receptors on epithelial cell (Madin-Darby canine kidney) monolayers: asymetric distribution correlates with functional difference. J Biol Chem 1991; 266:9263-9270.
40. Antohe F, Serban G, Radulescu L, Simionescu M. Transcytosis of albumin in endothelial cells is brefeldin A independent. Endothelium 1997; 5:125-136.
41. Cho MJ, Scieszka JF, Cramer CT, Thompson DP, Vidmar TJ. Neutrophil-mediated transport of liposomes across the Madin Darby canine kidney epithelial cell monolayer. Pharmaceut Res 1989; 6:78-84.
42. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1958; 234:466-468.
43. Hormia M, Lehto VP, Virtanen I. Intracellular localization of factor VIII-related antigen and fibronectin in cultured human endothelial cells; evidence for divergent routes in intracellular translocation. Eur J Cell Biol 1984; 33:217-228.
44. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87:206-210.
45. Hong K, Friend DS, Glabe CG, Papahadjopoulos D. Liposomes containing colloidal gold are a useful probe of liposome-cell interactions. Biochim Biophys Acta 1983; 732:320-323.
46. Simionescu N, Simionescu M. Galloylglucoses of low molecular weight as mordant in electron microscopy. I. Procedure and evidence for mordanting effect. J Cell Biol 1976; 70:608-621.
47. Rutten MJ, Hoover RL, Karnovsky MJ. Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res 1987; 425:301-310.
48. Allen TM, Austin GA, Chonn A, Lin L, Lee KC. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta 1991; 1061:56-64.
49. Yahata Y, Murakami S, Hasimoto K. A new histamine measurement system employing a confocal laser microscope and cultured human dermal microvascular endothelial cells. J Dermatol Sci 2003; 32:201-207.
50. Majno G, Stephen MS, Leventhal M. Endothelial contraction induced by histamine-type mediators. J Cell Biol 1969; 42:647-672.
51. Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, Talano JV. Blood histamine is associated with coronary artery disese, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med 2002; 6:583-592.
52. Herlyn M, Malkowicz SB. Biology of disease: regulatory pathways in tumor growth and invasion. Lab Invest 1991; 65:227-262.
53. Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, Dewhirst MW. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumour tissue. Cancer Res 1993; 53:3765-3770.
54. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res 1994; 54:3352-3356.
55. Wu NZ, Braun RD, Gaber MH, Lim GM, Ong ET, Shan S, Papahadjopoulos D, Dewhirst MW. Simultaneous measurement of liposome extravasation and content release in tumors. Microcirculation 1997; 4:83-101.
56. Simionescu N. Cellular aspects of transcapillary exchange. Physiol Rev 1983; 63:1536-1579.
57. Clough G. Relationship between microvascular permeability and ultrastructure. Prog Biophys Molec Biol 1991; 55:47-69.
58. Majno G, Palade GE. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961; 11:571-605.
59. Rosenecker J, Zhang W, Hong K, Lausier J, Geppetti P, Yoshihara S, Papahadjopoulos D, Nadel JA. Increased liposome extravasation in selected tissues: effect of substance P. Proc Natl Acad Sci U S A 1996; 93:7236-7241.
60. Antohe F, Heltianu C, Simionescu N. Further evidence for the distribution and nature of histamine receptors on microvascular endothelium. Microcirc Endoth Lymph 1986; 3:163-185.
61. Bottaro D, Shepro D, Peterson S, Hechtmann HB. Serotonin, norepinephrine and histamine mediation of endothelial cell barrier function in vitro. J Cell Physiol 1986; 128:189-194.
62. Carman-Krzau M. Endothelial catecholamine and histamine receptors. Jug Physiol Pharmacol Acta 1989; 25:19-20.
63. Haselton FR, Alexander JS, Mueller SN, Fishman AP. Modulation of endothelial paracellular permeability as mechanistic approach. In: Simionescu N, Simionescu M, eds. Endothelial Cell Dysfunctions. New York: Plenum Press, 1992:103-126.
64. Huang AJ, Silverstein SC. Mechanisms of neutrophil migration across endothelium. In: Simionescu N, Simionescu M, eds. Endothelial Cell Dysfunctions. New York: Plenum Press, 1992:201-231.
65. Furie MB, Naprstek BL, Silverstein SC. Migration of neutrophils across monolayers of cultures endothelial cells: an in vitro model for leucocyte extravasation. J Cell Sci 1987; 88:161-175.
66. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 1985; 76:2003-2011.
67. Stoolman MA. Adhesion molecules controlling lymphocyte migration. Cell 1989; 56:907-910.
68. Gybulsky IM, Gimbrone MA Jr. Endothelial-leukocyte adhesion molecules in acute inflammation and atherogenesis. In: Simionescu N, Simionescu M, eds. Endothelial Cell Dysfunctions. New York: Plenum Press, 1992:129-170.
69. 2 integrins in vivo. Proc Natl Acad Sci U S A 1991; 88:7538-7542.
70. Huber AR, Kunkel SL, Todd RF III, Weiss SL. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254:99-102.